BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer

  Mr. Shah has been serving as the Interim President and Chief Executive Officer since March 2017.

  October 31, 2017

   · 

  4 min read
• Drug Development

  Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes

  Janssen sponsored the application for Fast Track designation utilizing preliminary data from IMerge, the ongoing clinical trial being conducted by Janssen in lower risk MDS.

  October 31, 2017

   · 

  7 min read
• Business

  Intellia Therapeutics Announces Third Quarter 2017 Financial Results

  The Company made considerable progress in its Transthyretin Amyloidosis program using its proprietary lipid nanoparticle delivery system.

  October 31, 2017

   · 

  13 min read
• Business

  Spark Therapeutics to Host Conference Call on Tuesday, Nov. 7 at 8:30 a.m. ET to Discuss Third Quarter 2017 Results

  The company will host a conference call on Tuesday, Nov. 7, 2017, at 8:30 a.m. ET.

  October 31, 2017

   · 

  1 min read
• Business

  ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November

  Management will host an investment community conference call at 8:00 a.m. ET.

  October 31, 2017

   · 

  2 min read
• Business

  Antares Pharma to Report Third Quarter 2017 Financial and Operating Results and Host Webcast and Conference Call

  Management will host a webcast and conference call at 8:30 a.m. ET on November 7, 2017 to discuss the results.

  October 31, 2017

   · 

  5 min read
• Business

  Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company

  Mr. Wechsler is a seasoned pharma executive with more than 25 years of healthcare experience.

  October 31, 2017

   · 

  14 min read
• Business

  ASPiRA Labs Announces OVA1 Contract With Louisiana Blue Cross Blue Shield

  This BCBS plan is in addition to existing TriCare, Medicare, and Medicaid plans that have OVA1 covered in Louisiana.

  October 31, 2017

   · 

  3 min read
• Drug Development

  Aimmune Therapeutics Announces Publication in The Journal of Allergy and Clinical Immunology: In Practice of Positive AR101 Data from ARC001 Phase II Clinical Trial

  The ARC001 study met its primary endpoint, providing evidence that AR101 has immunomodulatory activity, which, after approximately six months of treatment, significantly reduced clinical reactivity in almost 80 percent of the peanut-allergic subjects randomized to AR101 treatment.

  October 31, 2017

   · 

  8 min read
• Biotech Beach

  CytRx Announces Reverse Stock Split

  CytRx today announced the previously disclosed 1-for-6 reverse stock split of its issued and outstanding common stock will become effective as of the commencement of trading on Wednesday, November 1, 2017

  October 31, 2017

   · 

  3 min read